GORE® Endovascular Stent Graft System with Active Control
GPTKB entity
Statements (63)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:medical_devices
|
| gptkbp:advances |
continuously evolving
|
| gptkbp:benefits |
minimally invasive procedure
|
| gptkbp:clinical_guidelines_updates |
regularly reviewed for best practices
|
| gptkbp:clinical_outcomes_monitoring |
integral to patient care.
|
| gptkbp:clinical_trial |
conducted for efficacy
abdominal aortic aneurysm show positive outcomes supports ongoing innovation |
| gptkbp:clinical_use |
requires multidisciplinary approach
used in various vascular surgeries |
| gptkbp:competitors |
competes with other stent grafts
|
| gptkbp:complications |
risk of endoleak
|
| gptkbp:customer_satisfaction |
high satisfaction rates reported
|
| gptkbp:design |
modular design
|
| gptkbp:device_innovation |
focus on improving patient care
|
| gptkbp:device_longevity |
designed for durability
|
| gptkbp:device_specifications |
detailed in product literature
|
| gptkbp:effective_date |
FDA approved
|
| gptkbp:events |
necessary after implantation
|
| gptkbp:features |
Active Control technology
|
| gptkbp:feedback |
collected for product improvement
|
| https://www.w3.org/2000/01/rdf-schema#label |
GORE® Endovascular Stent Graft System with Active Control
|
| gptkbp:is_effective_against |
demonstrated in studies
supported by clinical evidence |
| gptkbp:manufacturer |
gptkb:W._L._Gore_&_Associates
|
| gptkbp:market_position |
available in multiple sizes
|
| gptkbp:material |
gptkb:expanded_polytetrafluoroethylene_(e_PTFE)
|
| gptkbp:notable_technology |
radiopaque markers for visibility
|
| gptkbp:partnerships |
collaborates with hospitals and clinics
|
| gptkbp:patient_education |
important for informed consent
provided to enhance understanding |
| gptkbp:patient_follow-up |
recommended at regular intervals
|
| gptkbp:patient_outcomes_tracking |
important for quality improvement
|
| gptkbp:patient_population |
adults
primarily older adults used in diverse populations |
| gptkbp:patient_recovery |
typically rapid recovery
|
| gptkbp:post-operative_monitoring |
required for complications
|
| gptkbp:price |
considered cost-effective
|
| gptkbp:provides_guidance_on |
included in treatment guidelines
|
| gptkbp:recruitment |
based on anatomical criteria
|
| gptkbp:regulatory_compliance |
meets international standards
obtained in multiple countries |
| gptkbp:research |
ongoing for long-term effects
|
| gptkbp:safety |
prioritized in design and use
|
| gptkbp:safety_features |
generally safe with low complication rates
|
| gptkbp:shipping_options |
endovascular delivery
|
| gptkbp:specialties |
requires imaging guidance
transfemoral access evolving with technology advancements |
| gptkbp:surgeon_expertise |
requires specialized training
|
| gptkbp:surgical_outcomes_analysis |
conducted to assess performance
|
| gptkbp:training |
essential for effective use
|
| gptkbp:training_programs |
available for healthcare providers
|
| gptkbp:treatment |
improved survival rates
evaluated through patient registries includes bleeding and infection monitored through registries |
| gptkbp:type |
stent graft
|
| gptkbp:used_for |
treatment of aortic aneurysms
|
| gptkbp:bfsParent |
gptkb:Gore_Interventional_Devices
|
| gptkbp:bfsLayer |
7
|